These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16183079)
1. 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of PI3K/Akt and the suppression of calcineurin/NF-AT3 signaling pathways in rats. Wu CH; Liu JY; Wu JP; Hsieh YH; Liu CJ; Hwang JM; Lee SD; Chen LM; Chang MH; Kuo WW; Shyu JC; Tsai JH; Huang CY Life Sci; 2005 Dec; 78(4):347-56. PubMed ID: 16183079 [TBL] [Abstract][Full Text] [Related]
2. Distinct cardioprotective effects of 17β-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female rats. Tagashira H; Bhuiyan S; Shioda N; Fukunaga K Menopause; 2011 Dec; 18(12):1317-26. PubMed ID: 21844826 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation. Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443 [TBL] [Abstract][Full Text] [Related]
4. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476 [TBL] [Abstract][Full Text] [Related]
5. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats. Kuo WW; Chung LC; Liu CT; Wu SP; Kuo CH; Tsai FJ; Tsai CH; Lu MC; Huang CY; Lee SD Cell Biochem Funct; 2009 Oct; 27(7):479-87. PubMed ID: 19718675 [TBL] [Abstract][Full Text] [Related]
6. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693 [TBL] [Abstract][Full Text] [Related]
7. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007 [TBL] [Abstract][Full Text] [Related]
8. Impact of estradiol on insulin signaling in the rat heart. Koricanac G; Milosavljevic T; Stojiljkovic M; Zakula Z; Tepavcevic S; Ribarac-Stepic N; Isenovic ER Cell Biochem Funct; 2009 Mar; 27(2):102-10. PubMed ID: 19226537 [TBL] [Abstract][Full Text] [Related]
9. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Bhuiyan MS; Shioda N; Fukunaga K Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1606-14. PubMed ID: 17878225 [TBL] [Abstract][Full Text] [Related]
10. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Patten RD; Pourati I; Aronovitz MJ; Baur J; Celestin F; Chen X; Michael A; Haq S; Nuedling S; Grohe C; Force T; Mendelsohn ME; Karas RH Circ Res; 2004 Oct; 95(7):692-9. PubMed ID: 15345655 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
12. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448 [TBL] [Abstract][Full Text] [Related]
13. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Pu WT; Ma Q; Izumo S Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489 [TBL] [Abstract][Full Text] [Related]
14. Cardiac hypertrophy induced by prostaglandin F(2alpha) may be mediated by calcineurin signal transduction pathway in rats. Jiang QS; Huang XN; Yang GZ; Dai ZK; Zhou QX; Shi JS; Wu Q Sheng Li Xue Bao; 2005 Dec; 57(6):742-8. PubMed ID: 16344900 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828 [TBL] [Abstract][Full Text] [Related]
17. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3. Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415 [TBL] [Abstract][Full Text] [Related]
18. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Molkentin JD Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472 [TBL] [Abstract][Full Text] [Related]
19. 17β-Estradiol up-regulates Nrf2 via PI3K/AKT and estrogen receptor signaling pathways to suppress light-induced degeneration in rat retina. Zhu C; Wang S; Wang B; Du F; Hu C; Li H; Feng Y; Zhu R; Mo M; Cao Y; Li A; Yu X Neuroscience; 2015 Sep; 304():328-39. PubMed ID: 26211446 [TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]